First National Bank of Mount Dora Trust Investment Services boosted its stake in Clorox Co (NYSE:CLX) by 4.2% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 7,961 shares of the company’s stock after purchasing an additional 320 shares during the period. First National Bank of Mount Dora Trust Investment Services’ holdings in Clorox were worth $1,222,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. State Street Corp grew its holdings in shares of Clorox by 2.6% in the third quarter. State Street Corp now owns 8,336,740 shares of the company’s stock valued at $1,266,101,000 after purchasing an additional 207,856 shares in the last quarter. Parnassus Investments CA increased its position in shares of Clorox by 0.4% during the third quarter. Parnassus Investments CA now owns 4,651,499 shares of the company’s stock worth $706,423,000 after acquiring an additional 17,409 shares during the period. California Public Employees Retirement System raised its stake in shares of Clorox by 7.7% in the third quarter. California Public Employees Retirement System now owns 1,040,151 shares of the company’s stock valued at $157,968,000 after acquiring an additional 74,260 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of Clorox by 8.8% in the second quarter. Price T Rowe Associates Inc. MD now owns 632,461 shares of the company’s stock valued at $96,836,000 after acquiring an additional 51,252 shares in the last quarter. Finally, Parametric Portfolio Associates LLC boosted its holdings in Clorox by 1.3% in the third quarter. Parametric Portfolio Associates LLC now owns 617,126 shares of the company’s stock valued at $93,723,000 after purchasing an additional 7,673 shares during the period. 77.94% of the stock is currently owned by institutional investors.
Shares of NYSE:CLX traded down $1.83 on Friday, hitting $158.07. 50,141 shares of the company’s stock were exchanged, compared to its average volume of 706,252. The firm’s 50-day moving average is $153.60 and its 200 day moving average is $153.98. The company has a market capitalization of $19.96 billion, a PE ratio of 25.09, a P/E/G ratio of 5.13 and a beta of 0.39. Clorox Co has a 1-year low of $143.58 and a 1-year high of $166.90. The company has a debt-to-equity ratio of 4.69, a quick ratio of 0.52 and a current ratio of 0.87.
The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be issued a $1.06 dividend. This represents a $4.24 annualized dividend and a dividend yield of 2.68%. The ex-dividend date of this dividend is Tuesday, January 28th. Clorox’s payout ratio is 67.09%.
In related news, SVP Denise Garner sold 725 shares of the company’s stock in a transaction dated Friday, November 22nd. The stock was sold at an average price of $146.34, for a total value of $106,096.50. Following the completion of the sale, the senior vice president now directly owns 5,805 shares of the company’s stock, valued at approximately $849,503.70. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP Andrew J. Mowery sold 5,648 shares of the company’s stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $146.29, for a total value of $826,245.92. Following the completion of the sale, the senior vice president now directly owns 15,920 shares of the company’s stock, valued at $2,328,936.80. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.
Several equities research analysts have weighed in on CLX shares. Credit Suisse Group cut their price target on Clorox from $172.00 to $168.00 and set an “outperform” rating on the stock in a report on Thursday, October 3rd. Citigroup decreased their price objective on Clorox from $167.00 to $163.00 and set a “neutral” rating for the company in a research note on Thursday, October 3rd. Morgan Stanley reissued an “underweight” rating and set a $134.00 price objective (down from $144.00) on shares of Clorox in a research report on Monday, September 30th. Bank of America cut their target price on shares of Clorox from $165.00 to $160.00 and set a “neutral” rating on the stock in a research note on Thursday, October 3rd. Finally, UBS Group reduced their target price on shares of Clorox from $128.00 to $125.00 and set a “sell” rating on the stock in a report on Thursday, October 3rd. Five investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $152.17.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Recommended Story: Most Volatile Stocks – What Investors Need to Know to Maximize ROI
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.